GOFFX | RSEBX | GOFFX / RSEBX | |
Total Expense Ratio | 0.84 | 1.45 | 58% |
Annual Report Gross Expense Ratio | 0.84 | 1.45 | 58% |
Fund Existence | 6 years | 11 years | - |
Gain YTD | 6.045 | 9.389 | 64% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 1000000 | 250 | 400,000% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 2.4B | 80.3B | 3% |
Annual Yield % from dividends | 0.34 | 0.23 | 147% |
Returns for 1 year | 2.51 | 9.79 | 26% |
Returns for 3 years | -1.96 | 20.18 | -10% |
Returns for 5 years | -25.95 | 12.50 | -208% |
Returns for 10 years | N/A | 44.85 | - |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
SBHIX | 22.90 | 0.18 | +0.79% |
Saratoga Health & Biotechnology I | |||
OEGYX | 34.48 | -0.07 | -0.20% |
Invesco Discovery Mid Cap Growth Y | |||
MUERX | 36.03 | -0.13 | -0.36% |
MFS Blended Research Core Equity R1 | |||
VYSDX | 10.61 | -0.05 | -0.47% |
Voya Small Company R | |||
MXXIX | 60.91 | -0.47 | -0.77% |
Marsico Midcap Growth Focus Fund |